Poliovirus receptor CD155-targeted oncolysis of glioma

Neuro-Oncology

Volumn 6, Issue 3, 2004, Pages 208-217

  Merrill, Melinda K ^a   Bernhardt, Guenter ^b   Sampson, John H ^a   Wikstrand, Carol J ^a   Bigner, Darell D ^a   Gromeier, Matthias ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD155 ANTIGEN; LIVE VACCINE; LYMPHOCYTE ANTIGEN; POLIOMYELITIS VACCINE; RECOMBINANT VACCINE; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CANCER CELL DESTRUCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA MODIFICATION; DRUG EFFICACY; DRUG TARGETING; GLIOMA; HUMAN; HUMAN CELL; HUMAN RHINOVIRUS; HUMAN TISSUE; POLIOMYELITIS VIRUS; VACCINE PRODUCTION;

CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE EXPRESSION REGULATION, VIRAL; GLIOMA; HUMANS; MEMBRANE PROTEINS; POLIOVIRUS; RECEPTORS, VIRUS; RHINOVIRUS; SPINAL CORD; TUMOR CELLS, CULTURED;

EID: 4344646381     PISSN: 15228517     EISSN: None     Source Type: Journal    
DOI: 10.1215/S1152851703000577     Document Type: Article

References (48)

1. Asaoka, K., Tada, M., Sawamura, Y, Ikeda, J., and Abe, H. (2000) Dependence of efficient adenoviral gene delivery in malignant glioma cells on the expression levels of the Coxsackievirus and adenovirus receptor. J. Neurosurg. 92, 1002-1008.
2. Banker, G., and Goslin, K., Eds. (1998) Culturing Nerve Cells. Cambridge, Mass.: MIT press.
3. Baury, B., Geraghty, R.J., Masson, D., Lustenberger, R, Spear, P.G., and Denis, M.G. (2001) Organization of the rat Tage4 gene and herpesvirus entry activity of the encoded protein. Gene 265, 185-194.
4. Bergelson, J.M., Cunningham, J.A., Droguett, G., Kurt-Jones, E.A., Krithivas, A., Hong, J.S., Horwitz, M.S., Crowell, R.L., and Finberg, R.W. (1997) Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275, 1320-1323.
5. Bernhardt, G., Bibb, J.A., Bradley, J., and Wimmer, E. (1994) Molecular characterization of the cellular receptor for poliovirus. Virology 199, 105-113.
6. Bigner S.H., Humphrey, P.A., Wong, A.J., Vogelstein, B., Mark, J., Friedman, H.S., and Bigner, D, D. (1990) Characterization of the epidermal growth factor receptor in human glioma cell lines and xenografts. Cancer Res. 50, 8017-8022.
7. Bischoff, J.R., Kirn, D.H., Williams, A., Heise, C., Horn, S., Muna, M., Ng, L., Nye, J.A., Sampson-Johannes, A., Fattaey, A., and McCormick, F (1996) An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science 274, 373-376.
8. Coffey, M.C., Strong, J,E., Forsyth, P.A., and Lee, P.W. (1998) Reovirus therapy of tumors with activated Ras pathway. Science 282, 1332-1334.
9. Curiel, D.T. (1999) Strategies to adapt adenoviral vectors for targeted delivery. Ann. N. Y. Acad. Sci. 886, 158-171.
10. Denis, M.G. (1998) Characterization, cloning and expression of the Tage4 gene, a member of the immunoglobulin superfamily. Int. J. Oncol. 12, 997-1005.
11. DePace, N. (1912) Sulla scomparsa di un enorme cancro vegetante del collo dell'utero senza cura chirurgica. Ginecologia 9, 82-89.
12. Douglas, J.T, Kim, M., Sumerel, L.A., Carey, D.E., and Curiel, D.T. (2001) Efficient oncolysis by a replicating adenovirus (ad) in vivo is critically dependent on tumor expression of primary ad receptors. Cancer Res, 61, 813-817.
13. Dufresne, A.T., Dobrikova, E.Y., Schmidt, S., and Gromeier, M. (2002) Genetically stable picornavirus expression vectors with recombinant internal ribosomal entry sites. J. Virol. 76, 8966-8972.
14. Gladson, C.L., Wilcox, J.N., Sanders, L., Gillespie, G.Y, and Cheresh, D.A. (1995) Cerebral microenvironment influences expression of the vitronectin gene in astrocytic tumors. J. Cell Sci. 108, 947-956.
15. Goldbrunner, R.H., Bernstein, J.J., and Tonn, J.C. (1999) Cell-extracellular matrix interaction in glioma invasion. Acta Neurochir. 141, 295-305.
16. Goodrich, L.V., Milenkovic, L., Higgins, K.M., and Scott, M.P. (1997) Altered neural cell fates and medulloblastoma in mouse patched mutants. Science 277, 1109-1113.
17. Gromeier, M. (2001). Viruses as therapeutic agents against malignant disease of the central nervous system. J. Natl. Cancer Inst. 93, 889-890.
18. Gromeier, M. (2002) Viruses for treating cancer. ASM News 68, 438-445.
19. Gromeier, M., and Wimmer, E. (2001) Viruses for the treatment of malignant glioma. Curr. Opin. Mol. Ther. 3, 503-508.
20. Gromeier, M., Alexander, L., and Wimmer, E. (1996) Internal ribosomal entry site substitution eliminates neurovirulence in intergeneric poliovirus recombinants. Proc. Natl. Acad. Sci. USA 93, 2370-2375.
21. Gromeier, M., Bossert, B., Arita, M., Nomoto, A., and Wimmer, E. (1999) Dual stem loops within the poliovirus internal ribosomal entry site control neurovirulence. J. Virol. 73, 958-964.
22. Gromeier, M., Solecki, D., Patel, D.D., and Wimmer, E. (2000a) Expression of the human poliovirus receptor/CD155 gene during embryonic development of the central nervous system: Implications for the pathogenesis of poliomyelitis. Virology 273, 248-257.
23. Gromeier, M., Lachmann, S., Rosenfeld, M.R., Gutin, P.H., and Wimmer, E. (2000b) Intergeneric poliovirus recombinants for the treatment of malignant glioma. Proc. Natl. Acad. Sci. USA 97, 6803-6808.
24. Harlow, E., and Lane, D. (1988) Antibodies: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
25. Izumoto, S., Ohnishi, T., Arita, N., Hiraga, S., Taki, T., and Hayakawa, T. (1996) Gene expression of neural cell adhesion molecule L1 in malignant gliomas and biological significance of L1 in glioma invasion. Cancer Res. 56, 1440-1444.
26. Kinzler, K.W., Bigner, S.H., Bigner, D.D., Trent, J.M., Law, M.L., O'Brien, S.J., Wong, A.J., and Vogelstein, B. (1987) Identification of an amplified, highly expressed gene in a human glioma. Science 236, 70-73.
27. Koike, S., Taya, C., Kurata, T, Abe, S., Ise, I., Yonekawa, H., and Nomoto, A. (1991) Transgenic mice susceptible to poliovirus. Proc. Natl. Acad. Sci. USA 88, 951-955.
28. Lange, R., Peng, X., Wimmer, E., Lipp, M., and Bernhardt, G. (2001) The poliovirus receptor CD155 mediates cell-to-matrix contacts by specifically binding to vitronectin. Virology 285, 218-227.
29. Li, D., Duan, L., Freimuth, P., and O'Malley, B.W., Jr. (1999) Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer. Clin. Cancer Res. 5, 4175-4181.
30. Li, Y., Pong, R.C., Bergelson, J.M., Hall, M.C., Sagalowsky, A.I., Tseng, C.P., Wang, Z., and Hsieh, J.T (1999) Loss of adenoviral receptor expression in human bladder cancer cells: A potential impact on the efficacy of gene therapy. Cancer Res. 59, 325-330.
31. Martuza, R.L., Malick, A., Markert, J.M., Ruffner, K.L., and Coen, D.M. (1991) Experimental therapy of human glioma by means of a genetically engineered virus mutant. Science 252, 854-856.
32. Masson, D., Jarry, A., Baury, B., Blanchardie, P., Laboisse, C., Lustenberger, P., and Denis, M.G. (2001) Overexpression of the CD155 gene in human colorectal carcinoma. Gut 49, 236-240.
33. Mendelsohn, C.L., Wimmer, E., and Racaniello, V.R. (1989) Cellular receptor for poliovirus: Molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell 56, 855-865.
34. Nobis, P., Zibirre, R., Meyer, G., Kuhne, J., Warnecke, G., and Koch, G. (1985) Production of a monoclonal antibody against an epitope on HeLa cells that is the functional poliovirus binding site. J. Gen. Virol. 66, 2563-2569.
35. Ochiai, H., Moore, S.A., Archer, G.E., Okamura, T, Chewning, T.A., Marks, J.R., Sampson J.H., and Gromeier, M. (2004) Treatment of intracerebral neoplasia and neoplastic meningitis with regional delivery of oncolytic recombinant poliovirus. Clin. Cancer Res. In press.
36. Ren, R.B., Constantini, F., Gorgacz, E.J., Lee, J.J., and Racaniello, V.R. (1990) Transgenic mice expressing a human poliovirus receptor: A new model for poliomyelitis. Cell 63, 353-362.
37. Rickman, D.S., Tyagi, R., Zhu, XX, Bobek, M.P., Song, S., Blaivas, M., Misek, D.E., Israel, M.A., Kurnit, D.M., Ross, D.A., Kish, PE., and Hanash, S.M. (2001) The gene for the axonal cell adhesion molecule TAX-1 is amplified and aberrantly expressed in malignant glioma. Cancer Res. 61, 2162-2168.
38. Sasaki, H., Yoshida, K., Ikeda, E., Asou, H., Inaba, M., Otani, M., and Kawase, T. (1998) Expression of the neural cell adhesion molecule in astrocytic tumors: An inverse correlation with malignancy. Cancer 82, 1921-1931.
39. Sehgal, A., Boynton, A.L., Young, R.F., Vermeulen, S.S., Yonemura, K.S., Koehler, E.P., Aldape, H.C., Simrell, C.R., and Murphy, G.P. (1998) Cell adhesion molecule Nr-CAM is over-expressed in human brain tumors. Int. J. Cancer 76, 451-458.
40. Shaw, G., Morse, S., Ararat, M., and Graham, F.L. (2002) Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. FASEB J. 16, 869-871.
41. Sincovics, J.G., and Horvath, J. (1993) New developments in the virus therapy of cancer: A historical review. Intervirology 36, 193-214.
42. Solecki, D.J., Wimmer, E., Lipp, M., and Bernhardt, G. (1999) Identification and characterization of the cis-acting elements of the human CD155 gene core promoter. J. Biol. Chem. 274, 1791-1800.
43. Solecki, D.J., Bernhardt, G., Lipp, M., and Wimmer, E. (2000) Identification of a nuclear respiratory factor-1 binding site within the core promoter of the human polio virus receptor/CD155 gene. J. Biol. Chem. 275, 12453-12462.
44. Solecki, D.J., Gromeier, M., Bernhardt, G., and Wimmer, E. (2002) Expression of the human poliovirus receptor/CD155 gene is activated by sonic hedgehog. J. Biol. Chem. 277, 25697-25702.
45. Stojdl, D.F., Litchy, B., Knowles, S., Marius, R., Atkins, H., Sonenberg, N., and Bell, J.C. (2000) Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus. Nat. Med. 6, 821-825.
46. Tomko, R.P., Xu, R., and Philipson, L. (1997) HCAR and MCAR: The human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc. Natl. Acad. Sci. USA 94, 3352-3356.
47. Uhm, J.H., Dooley, N.P., Kyritsis, A.P., Rao, J.S., and Gladson, C.L. (1999) Vitronectin, a glioma-derived extracellular matrix protein, protects tumor cells from apoptotic death. Clin. Cancer Res. 5, 1587-1594.
48. Zülch, K.J. (1979) Histological Typing of Tumours of the Central Nervous System (International Histological Classification of Tumours, no. 21). Geneva: World Health Organization, pp. 19-20.